Log in to save to my catalogue

Antiparkinsonian Agents in Investigational Polymeric Micro- and Nano-Systems

Antiparkinsonian Agents in Investigational Polymeric Micro- and Nano-Systems

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_b8f3ae5f29b949b08bb8ed9be8ea6264

Antiparkinsonian Agents in Investigational Polymeric Micro- and Nano-Systems

About this item

Full title

Antiparkinsonian Agents in Investigational Polymeric Micro- and Nano-Systems

Publisher

Switzerland: MDPI AG

Journal title

Pharmaceutics, 2022-12, Vol.15 (1), p.13

Language

English

Formats

Publication information

Publisher

Switzerland: MDPI AG

More information

Scope and Contents

Contents

Parkinson’s disease (PD) is a devastating neurodegenerative disease characterized by progressive destruction of dopaminergic tissue in the central nervous system (CNS). To date, there is no cure for the disease, with current pharmacological treatments aimed at controlling the symptoms. Therefore, there is an unmet need for new treatments for PD. In...

Alternative Titles

Full title

Antiparkinsonian Agents in Investigational Polymeric Micro- and Nano-Systems

Authors, Artists and Contributors

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_b8f3ae5f29b949b08bb8ed9be8ea6264

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_b8f3ae5f29b949b08bb8ed9be8ea6264

Other Identifiers

ISSN

1999-4923

E-ISSN

1999-4923

DOI

10.3390/pharmaceutics15010013

How to access this item